SCHEMBL7587940

SCHEMBL7587940

C=CCCCCCCCCCC(C)O

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
ALDH1A1 P00352 5/20 0.50
TSHR P16473 2/20 0.48
USP2 O75604 4/20 0.46
CYP3A4 P08684 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
HPGD P15428 1/20 0.46
CYP2C9 P11712 1/20 0.43
ABCC4 O15439 1/20 0.41
LPAR3 Q9UBY5 2/20 0.41
LMNA P02545 2/20 0.41
LPAR2 Q9HBW0 1/20 0.41
RECQL P46063 1/20 0.40
TRPA1 O75762 2/20 0.36
TRPV1 Q8NER1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3123691 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL10027888 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL9540135 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL3121302 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL10027891 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL3111454 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL2139099 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL17494163 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL9460912 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4
SCHEMBL9332509 1.00 MAPT (0.50) MAPTALDH1A1TSHRUSP2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4737464-A2 METAL COMPLEX AND METHOD FOR PRODUCING THE SAME, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE METAL COMPLEX, AND METHODS FOR PRODUCING ALPHA-OLEFIN POLYMER AND COPOLYMER USING THE CATALYST FOR OLEFIN POLYMERIZATION The University Of Tokyo (JP) 2026-05-06 EP disclosed
EP-3476858-B1 METAL COMPLEX AND METHOD FOR PRODUCING THE SAME, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE METAL COMPLEX, AND METHODS FOR PRODUCING ALPHA-OLEFIN POLYMER AND COPOLYMER USING THE CATALYST FOR OLEFIN POLYMERIZATION UNIV TOKYO (JP) 2026-05-06 EP disclosed
CN-109601002-B Metal complex and preparation method thereof, catalyst for olefin polymerization and preparation method of alpha-olefin polymer 国立大学法人东京大学 2022-05-13 CN disclosed
US-11149099-B2 Metal complex and method for producing the same, catalyst component for olefin polymerization and catalyst for olefin polymerization containing the metal complex, and methods for producing α-olefin polymer and copolymer using the catalyst for olefin polymerization THE UNIVERSITY OF TOKYO (JP) 2021-10-19 US disclosed
US-11117984-B2 2021-09-14 US disclosed
US-20190263945-A1 METAL COMPLEX AND METHOD FOR PRODUCING THE SAME, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE METAL COMPLEX, AND METHODS FOR PRODUCING ?-OLEFIN POLYMER AND COPOLYMER USING THE CATALYST FOR OLEFIN POLYMERIZATION THE UNIVERSITY OF TOKYO (JP) 2019-08-29 US disclosed
EP-3476858-A1 METAL COMPLEX AND PRODUCTION METHOD THEREFOR, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING METAL COMPLEX, AND METHOD FOR PRODUCING POLYMER AND COPOLYMER OF -OLEFIN USING CATALYST FOR OLEFIN POLYMERIZATION The University Of Tokyo (JP) 2019-05-01 EP disclosed
WO-2002098935-A1 COPOLYMERS OF $G(A)-OLEFINS AND OF FUNCTIONAL MONOMERS, THEIR PRODUCTION AND THE USE THEREOF BOREALIS TECHNOLOGY OY (FI) 2002-12-12 WO disclosed
WO-1993002666-A1 SELF-STABILISED MULTIPHASE EMUSION STRUCTURES THOREL JEAN NOEL (FR) 1993-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11149099-B2 Metal complex and method for producing the same, catalyst component for olefin polymerization and catalyst for olefin polymerization containing the metal complex, and methods for producing α-olefin polymer and copolymer using the catalyst for olefin polymerization INTS9, AS3MT, CTR9 MAPT 3218/4885ALDH1A1 1371/4885TSHR 1746/4885
US-20190263945-A1 METAL COMPLEX AND METHOD FOR PRODUCING THE SAME, CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST FOR OLEFIN POLYMERIZATION CONTAINING THE METAL COMPLEX, AND METHODS FOR PRODUCING ?-OLEFIN POLYMER AND COPOLYMER USING THE CATALYST FOR OLEFIN POLYMERIZATION AS3MT, INTS9, CTR9 MAPT 3262/4885ALDH1A1 1438/4885TSHR 1797/4885
US-11117984-B2 INTS9, CTR9, OR10J3 MAPT 4105/4885ALDH1A1 2145/4885TSHR 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.